Clinical Trial Supply Chains Are Moving From Planning For Stability To Preparing For Uncertainty

By Laura Hay, senior director of global program management, Trax Group | 2025 Winner, everywoman Customer/Passenger (Leader) Award

When clinical trial supply chains were designed, many organizations built their strategies around predictability. Demand forecasts were created based on enrollment assumptions. Manufacturing schedules were aligned to expected timelines. Inventory was positioned based on planned patient needs. Transportation networks were built around established routes and operating conditions. However, today’s clinical supply environment looks very different.

Global supply chains are facing a level of uncertainty that traditional planning models were never designed to manage. Geopolitical instability, changing regulatory requirements, transportation disruptions, extreme weather events, and evolving clinical trial designs are creating new challenges for organizations responsible for ensuring patients receive critical therapies on time.

The question facing clinical supply leaders is no longer simply, “How do we optimize supply for the expected scenario?” The more important question is, “How prepared are we for the scenarios we cannot predict?”

Clinical trial supply chains are entering an era where resilience requires more than contingency plans created after problems occur. Organizations must begin building supply strategies that can adapt before disruption impacts operations. The most resilient supply chains are not those that avoid uncertainty. They are the ones designed to respond to it.

The Limits Of Traditional Clinical Supply Planning

For many years, clinical supply planning relied heavily on fixed assumptions. Enrollment forecasts were established. Packaging campaigns were scheduled. Inventory allocations were determined. Distribution plans were developed around expected trial progression. These processes remain essential, but the challenge is that clinical trials rarely follow a perfectly predictable path.

Enrollment may accelerate in one region while slowing in another. A site may activate later than expected. Regulatory approvals may shift timelines. A manufacturing delay may create pressure across multiple trial locations. When these changes occur, teams are often forced into reactive decision-making. They may need to expedite shipments, adjust inventory allocations, increase safety stock, or make last-minute changes to protect patient dosing windows. While these actions can help manage immediate challenges, they often come with increased costs and operational complexity. The opportunity is to move beyond reacting to disruption and toward building supply chains that are prepared for multiple possible outcomes.

Scenario Planning Is Becoming A Critical Supply Chain Capability

The future of clinical trial supply management will require organizations to think differently about uncertainty. Rather than planning for one expected outcome, supply teams are increasingly evaluating multiple scenarios and determining how different variables could impact supply availability.

Scenario planning allows organizations to ask important questions before disruption occurs:

• What happens if enrollment increases faster than expected?
• How would a manufacturing delay impact regional inventory levels?
• What alternatives exist if transportation routes are disrupted?
• How much inventory flexibility is needed to support changing demand?
• Which supply decisions need to be made earlier to protect timelines?

By modeling these possibilities in advance, organizations can identify vulnerabilities and create response strategies before they become urgent operational challenges.

The goal is not to predict every disruption. The goal is to understand where flexibility is needed most.

Global Events Are Changing The Way Organizations Think About Risk

Clinical trial supply chains are increasingly connected to events outside the traditional healthcare ecosystem. A geopolitical conflict can impact transportation routes. Extreme weather can delay shipments. Regulatory changes can affect product movement between regions. Manufacturing constraints can create global supply pressure. These risks are difficult to eliminate because many occur outside an organization’s direct control. However, organizations can improve how they prepare for them.

This requires greater visibility across the entire supply network, including manufacturing capacity, inventory positioning, transportation performance, and regional demand patterns. When supply teams have access to connected data, they can identify where risk exists and evaluate options before disruption occurs. Without that visibility, organizations are often left responding after the impact has already reached the patient level.

Inventory Strategy Must Balance Resilience And Efficiency

One of the biggest challenges in building resilient clinical supply chains is finding the right balance between preparedness and efficiency.

When uncertainty increases, organizations often respond by increasing inventory levels. Additional safety stock can provide protection against unexpected changes, but it can also create new challenges. Excess inventory increases storage costs, creates additional management complexity, and increases the risk of product expiry. The answer is not simply carrying more inventory; it is creating smarter inventory strategies supported by better visibility and more dynamic decision-making.

Organizations need to understand where inventory should be positioned, when it should move, and how much flexibility is required based on changing trial conditions. Resilience is not about having the most inventory. It is about having the right inventory in the right place at the right time.

Technology Is Enabling A More Adaptive Supply Chain

Technology is playing an increasingly important role in helping organizations manage uncertainty. Connected systems, advanced analytics, and artificial intelligence are creating opportunities to identify risks earlier and improve decision-making.

Predictive tools can help organizations analyze:

• enrollment changes
• inventory trends
• forecast accuracy
• transportation performance
• external risk indicators.

These insights allow supply teams to move from manual reaction toward proactive management. However, technology alone cannot solve supply chain complexity. The foundation remains accurate data, strong processes, and collaboration across clinical operations, supply teams, logistics providers, and manufacturing partners. Without alignment across these areas, even the most advanced tools will struggle to deliver meaningful impact.

Building The Future Of Clinical Supply Resilience

The future of clinical trial supply management will not be defined by perfect predictions. It will be defined by adaptability.

Organizations must recognize that uncertainty is now a permanent part of the operating environment. The ability to adjust quickly, identify risk early, and make informed decisions will become a defining characteristic of successful clinical supply organizations.

The strongest supply chains will not be those that assume disruption will not happen. They will be the ones designed with the understanding that disruption will happen — and prepared to respond.

As clinical trials become more global and complex, resilience will depend on the ability to combine technology, data, and strategic planning to create supply networks that can adapt in real time, because ultimately, clinical supply chain resilience is not only about protecting operations; it is about protecting the patients who depend on those operations.

About The Author:

Laura Hay is a global supply chain leader specializing in program management, customer success, and account strategy. She has a proven track record of leading cross-functional teams to deliver complex, high-impact initiatives on time and within budget. Laura is known for building strong stakeholder relationships, driving operational excellence, and managing multimillion-dollar programs. She is passionate about connecting people, processes, and technology to build scalable, resilient supply chain solutions that deliver measurable business impact.